729 related articles for article (PubMed ID: 26100531)
1. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.
Yilmaz MA; Duran C; Basaran M
J Endocrinol Invest; 2016 Jan; 39(1):45-53. PubMed ID: 26100531
[TBL] [Abstract][Full Text] [Related]
2. The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study.
Keskin Kurt R; Okyay AG; Hakverdi AU; Gungoren A; Dolapcioglu KS; Karateke A; Dogan MO
Arch Gynecol Obstet; 2014 Aug; 290(2):315-9. PubMed ID: 24643802
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes.
Çakıroğlu Y; Vural F; Vural B
J Endocrinol Invest; 2016 Aug; 39(8):899-907. PubMed ID: 26980590
[TBL] [Abstract][Full Text] [Related]
4. Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome.
Liu W; Li S; Lou X; Li D; Wang F; Zhang Z
Medicine (Baltimore); 2022 Jul; 101(29):e29678. PubMed ID: 35866809
[TBL] [Abstract][Full Text] [Related]
5. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
[TBL] [Abstract][Full Text] [Related]
6. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
7. Association between inflammatory biomarker serum procalcitonin and obesity in women with polycystic ovary syndrome.
Rashad NM; El-Shal AS; Abdelaziz AM
J Reprod Immunol; 2013 Apr; 97(2):232-9. PubMed ID: 23218400
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
9. The association of dynamic thiol-disulfide homeostasis and inflammatory markers in patients with polycystic ovary syndrome.
Aydın GA; Turan Özsoy HG; Ankaralı H; Özgen G; Neşelioğlu S
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):79-84. PubMed ID: 32039805
[TBL] [Abstract][Full Text] [Related]
10. Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.
Bozan N; Alpaycı M; Aslan M; Cankaya H; Kıroglu AF; Turan M; Ayral A; Senkoy E; Ilter S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3663-3672. PubMed ID: 27034281
[TBL] [Abstract][Full Text] [Related]
11. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
[TBL] [Abstract][Full Text] [Related]
12. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
13. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
14. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
[TBL] [Abstract][Full Text] [Related]
15. Periodontal status and high-sensitivity C-reactive protein levels in polycystic ovary syndrome with and without medical treatment.
Porwal S; Tewari S; Sharma RK; Singhal SR; Narula SC
J Periodontol; 2014 Oct; 85(10):1380-9. PubMed ID: 24592911
[TBL] [Abstract][Full Text] [Related]
16. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
17. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Kabil Kucur S; Gozukara I; Aksoy A; Uludag EU; Keskin H; Kamalak Z; Carlioglu A
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):862-5. PubMed ID: 25402193
[TBL] [Abstract][Full Text] [Related]
18. The effect of prolactin levels on MPV in women with PCOS.
Yilmaz Ö; Calan M; Kume T; Temur M; Yesil P; Senses MY
Clin Endocrinol (Oxf); 2015 May; 82(5):747-52. PubMed ID: 25359296
[TBL] [Abstract][Full Text] [Related]
19. High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome.
Kebapcilar L; Taner CE; Kebapcilar AG; Sari I
Arch Gynecol Obstet; 2009 Aug; 280(2):187-93. PubMed ID: 19107500
[TBL] [Abstract][Full Text] [Related]
20. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet's syndrome.
Alan S; Tuna S; Türkoğlu EB
Kaohsiung J Med Sci; 2015 Dec; 31(12):626-31. PubMed ID: 26709224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
